Other Faculty

Suzanne Fitzpatrick, Ph.D.

Dr. Suzanne Fitzpatrick is the Senior Advisor for Toxicology at the US Food and Drug Administration Human Foods Program. She is a board-certified toxicologist in the US and in Europe. Dr. Fitzpatrick helped develop the FDA DARPA NCATS program on Organs on a Chip and continues to work and give presentations on this evolving area. . Dr. Fitzpatrick co-chairs with EFSA the International Working Group on New Approach Methods for Food Safety under the International Liaison Group on Methods for Risk Assessment in Food, a coalition of food safety regulatory from over 29 countries and organizations.. She is on the International Regulatory Board for the EU APSIS (Risk Hunter, Precision Toc, Ontox) Research Collaboration for developing new non- animal methods. She is the FDA representative to PARC- The European Collaboration for Chemical Risk Assessment. She is on the Board of Directors for the International MPS Society. Dr. Fitzpatrick is the FDA lead and co-chair for ICCVAM and for Tox 21. She received her BA from the University of California at San Diego and her PhD from Georgetown University. When at GU for her postdoctoral research, she taught Histology and Gross Anatomy to freshman medical students.

Thomas Hartung, MD Ph.D.

Thomas Hartung, MD PhD, is the Doerenkamp-Zbinden-Chair for Evidence-based Toxicology with a joint appointment for Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, Baltimore. He holds a joint appointment as Professor for Pharmacology and Toxicology at University of Konstanz, Germany; he is also the Director of Centers for Alternatives to Animal Testing (CAAT) of both universities.

CAAT hosts the secretariat of the Evidence-based Toxicology Collaboration the Good Read-Across Practice Collaboration, the Good Cell Culture Practice Collaboration, the Green Toxicology Collaboration, and the Industry Refinement Working Group.

He is the former Head of the European Commission’s Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy, and has authored more than 490 scientific publications.

Lena Smirnova, Ph.D.

Lena Smirnova is Research Associate at Center for Alternatives to Animal Testing at Bloomberg School of Public Health. The main focus of her research is developmental neurotoxicity and the role of microRNA in gene/environment interactions in neurodevelopment and neurodegeneration.

From 2007 until 2012, she was a PostDoc at Federal Institute of Risk Assessment, Berlin, Germany, where she coordinated a pre-validation study in the field of inhalation toxicology in parallel to her research in neurotoxicology.

She received her PhD in Neuroscience in 2007 from Charité Free University, Berlin in 2007. The main focus of her research was microRNA in neural development and stem cell specification.

Lena Smirnova graduated from International Sakharov Environmental University, Minsk, Belarus in 2002. Her major subject was Radiobiology and Environmental Medicine.